The Effect of Curcumin and Its Nanoformulation on Adjuvant-induced Arthritis in Rats

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2015 Sep 9

PMID 26345159

Citations 38

Authors

Zhaoling Zheng

Yanhua Sun

Ziliang Liu

Mingqin Zhang

Chunqing Li

Hui Cai

Affiliations

Soon will be listed here.

Abstract

Background: Rheumatoid arthritis (RA), induced by the prolonged inappropriate inflammatory responses, is one of the most prevalent of all chronic inflammatory joint diseases. Curcumin (CM), a yellow hydrophobic polyphenol derived from the herb turmeric, has various pharmacological activities against many chronic diseases and acts by inhibiting cell proliferation and metastasis and downregulating various factors, including nuclear factor kappa B, interleukin-1β and TNF-α. Given the pathogenesis of RA, we hypothesized that the drug also has antiarthritic effects. The aims of the present study included the following: 1) examining the therapeutic effect of CM administered via intravenous (iv) injection on RA and 2) formulating the drug into oil-water nanoemulsions (Ns) to overcome the low oral bioavailability of CM and achieve oral delivery of the drug.

Methods: The effect of CM administered through iv injection on adjuvant-induced arthritis in rats was studied in terms of paw swelling, weight indices of the thymus and spleen, and pathological changes in nuclear factor kappa B expression and inflammatory cytokines. Methotrexate was used as a positive control. The CM-Ns were prepared using a high-pressure homogenizing method and characterized with respect to the particle size and morphology. The stability of the CM-Ns in simulated gastrointestinal (GI) fluids and in vitro release were also investigated. A pharmacokinetic study of the CM-Ns and suspensions in which the plasma levels were determined using an high performance liquid chromatography method and the pharmacokinetic parameters were calculated based on a statistical moment theory was also performed in rats.

Results: CM administered via iv injection had a therapeutic effect on RA similar to methotrexate. CM-Ns with a diameter of approximately 150 nm were successfully prepared, and the drug was well encapsulated into the Ns without degradation in simulated GI conditions. The area under the curve (AUC) and Cmax for the CM-Ns were more than threefold greater than those for the suspensions; moreover, similar decreases in the levels of TNF-α and interleukin-1β in both synovial fluid and blood serum were obtained from oral administration of CM-Ns and iv injection.

Conclusion: CM was an effective antiarthritic agent, and the present N formulation appeared to be a promising system that allowed RA therapy with CM to be converted from iv to oral administration.

Citing Articles

Potential Role of Dietary Phenolic Compounds in the Prevention and Treatment of Rheumatoid Arthritis: Current Reports.

Goncalves A, Rodrigues S, Fonseca R, Silva L Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794160 PMC: 11124183. DOI: 10.3390/ph17050590.

The Role of Aryl Hydrocarbon Receptor in Bone Biology.

Vyavahare S, Ahluwalia P, Gupta S, Kolhe R, Hill W, Hamrick M Int J Tryptophan Res. 2024; 17:11786469241246674.

PMID: 38757095 PMC: 11097734. DOI: 10.1177/11786469241246674.

Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.

Jacob S, Kather F, Morsy M, Boddu S, Attimarad M, Shah J Nanomaterials (Basel). 2024; 14(8).

PMID: 38668166 PMC: 11054677. DOI: 10.3390/nano14080672.

Emerging Phytochemical Formulations for Management of Rheumatoid Arthritis: A Review.

Pimple P, Shah J, Singh P Curr Drug Deliv. 2024; 22(1):15-40.

PMID: 38299275 DOI: 10.2174/0115672018270434240105110330.

Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.

Prabha J, Kumar M, Kumar D, Chopra S, Bhatia A Curr Drug Deliv. 2023; 21(8):1082-1105.

PMID: 37622715 DOI: 10.2174/1567201821666230825102748.

References

Li M, He J, Jiang L, Ng E, Wang H, Fu-Yuen Lam F . The anti-arthritic effects of Aconitum vilmorinianum, a folk herbal medicine in Southwestern China. J Ethnopharmacol. 2013; 147(1):122-7. DOI: 10.1016/j.jep.2013.02.018. View

Naidu V, Babu K, Thwin M, Satish R, Kumar P, Gopalakrishnakone P . RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. Chem Biol Interact. 2013; 203(2):467-79. DOI: 10.1016/j.cbi.2012.12.016. View

Mei L, Zhang Z, Zhao L, Huang L, Yang X, Tang J . Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2012; 65(6):880-90. DOI: 10.1016/j.addr.2012.11.005. View

Attili-Qadri S, Karra N, Nemirovski A, Schwob O, Talmon Y, Nassar T . Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci U S A. 2013; 110(43):17498-503. PMC: 3808655. DOI: 10.1073/pnas.1313839110. View

Kotta S, Khan A, Ansari S, Sharma R, Ali J . Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation. Int J Pharm. 2013; 462(1-2):129-34. DOI: 10.1016/j.ijpharm.2013.12.038. View

Naksuriya O, Okonogi S, Schiffelers R, Hennink W . Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014; 35(10):3365-83. DOI: 10.1016/j.biomaterials.2013.12.090. View

Fayaz Ahmad S, Attia S, Zoheir K, Ashour A, Bakheet S . Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment. Int Immunopharmacol. 2014; 19(1):52-9. DOI: 10.1016/j.intimp.2014.01.005. View

Ryan G, Kaminskas L, Porter C . Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. J Control Release. 2014; 193:241-56. DOI: 10.1016/j.jconrel.2014.04.051. View

Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey A . Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol Pharm. 2009; 6(3):861-72. DOI: 10.1021/mp900063t. View

10.

He W, Jin Z, Lv Y, Cao H, Yao J, Zhou J . Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy. Int J Pharm. 2014; 478(2):762-72. DOI: 10.1016/j.ijpharm.2014.12.039. View

11.

Zhang X, Sun J, Xin W, Li Y, Ni L, Ma X . Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells. Int Immunopharmacol. 2015; 25(1):88-95. DOI: 10.1016/j.intimp.2015.01.024. View

12.

He W, Lv Y, Zhao Y, Xu C, Jin Z, Qin C . Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect. Int J Pharm. 2015; 484(1-2):163-71. DOI: 10.1016/j.ijpharm.2015.02.053. View

13.

Wang Y, Wang S, Li Y, Jiang J, Zhou C, Li C . Therapeutic effect of Cryptotanshinone on collagen-induced arthritis in rats via inhibiting nuclear factor kappa B signaling pathway. Transl Res. 2015; 165(6):704-16. DOI: 10.1016/j.trsl.2014.12.004. View

14.

Shaikh J, Ankola D, Beniwal V, Singh D, Kumar M . Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009; 37(3-4):223-30. DOI: 10.1016/j.ejps.2009.02.019. View

15.

Yang M, Xiao C, Wu Q, Niu M, Yao Q, Li K . Anti-inflammatory effect of Sanshuibaihu decoction may be associated with nuclear factor-kappa B and p38 MAPK alpha in collagen-induced arthritis in rat. J Ethnopharmacol. 2009; 127(2):264-73. DOI: 10.1016/j.jep.2009.11.010. View

16.

Mohanty C, Sahoo S . The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010; 31(25):6597-611. DOI: 10.1016/j.biomaterials.2010.04.062. View

17.

Scott D, Wolfe F, Huizinga T . Rheumatoid arthritis. Lancet. 2010; 376(9746):1094-108. DOI: 10.1016/S0140-6736(10)60826-4. View

18.

He W, Tan Y, Tian Z, Chen L, Hu F, Wu W . Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats. Int J Nanomedicine. 2011; 6:521-33. PMC: 3065798. DOI: 10.2147/IJN.S17282. View

19.

McInnes I, Schett G . The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23):2205-19. DOI: 10.1056/NEJMra1004965. View

20.

Yallapu M, Jaggi M, Chauhan S . Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2011; 17(1-2):71-80. PMC: 3259195. DOI: 10.1016/j.drudis.2011.09.009. View